SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A recent market pullback and fears of a Black Monday crash tied to the 1987 anniversary dominate discussion, with traders split between those pointing to firmer futures as evidence the selloff may ease and bears warning of further declines, particularly in tech and AI stocks. Michael Burrys warnings about deteriorating market breadth add to the bearish debate, while others expect a rebound into earnings season.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp technology- and AI-linked selloff has QQQ traders debating whether the pullback will deepen or give way to an oversold rebound. Black Monday crash warnings are widely challenged, while some traders point to AI financing concerns and semiconductor weakness as reasons for caution.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Attention centers on Iovances ESMO presentations of lifileucel with pembrolizumab in frontline melanoma and lifileucel in sarcoma, with traders debating whether the abstracts offer meaningful updated efficacy and durability data or largely repeat older results. The shares recent weakness is also widely viewed as part of a broader biotech selloff rather than a company-specific reaction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS shares sold off sharply amid a broader biotech downturn and heavy options-expiration trading, with traders debating whether the move reflected market mechanics or concern about the companys silence. The main unresolved catalyst is the REGAL Phase 3 trials 80th event: the last reported count was 78, and bulls view the prolonged wait as potentially consistent with longer survival while skeptics question the delay and its implications.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Crude oils rally is being linked to fears of supply disruptions from Middle East conflict and attacks on shipping around the Strait of Hormuz, alongside damage to energy infrastructure in Russia and Ukraine. Traders are divided between those expecting tight supply to sustain oils strength and skeptics who see a war premium that could unwind if tensions ease or added Russian diesel supplies arrive.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is sliding amid a broad semiconductor selloff, as traders question whether AI infrastructure spending can deliver returns and weigh inflation and interest-rate risks. The community is split between calling the decline an oversold buying opportunityciting foundry prospects and upcoming earningsand warning that the AI trade and Intels valuation could face further pressure.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

ADAs volatile rebound and ongoing consolidation are fueling discussion, with traders watching for a breakout while bullish holders expect further gains and skeptics warn that rallies may fade. Some also point to Cardano adoption and partnership developments, but the dominant conversation centers on price momentum and resistance.

Anthropic

Anthropics anticipated mega-IPO is driving attention, with traders debating its potential valuation against rapid Claude growth and the companys heavy infrastructure spending and losses. Some see strong demand and a major listing ahead, while skeptics question the valuation and point to regulatory friction, including U.S. restrictions on access to its newest models.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins range-bound trading near key support has sparked debate over whether it can reclaim resistance or break lower, with traders focused on weekend volatility, leverage liquidations and a possible short squeeze. Bulls view the support tests as accumulation or a bear trap, while bears warn of further downside and point to weak momentum and ETF outflows.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins pullback and leveraged long liquidations are driving attention, with traders debating whether the selloff is a temporary leverage flush or a sign of deeper weakness. Some remain constructive on the longer-term trend, while concerns about higher yields, inflation and large-wallet selling add to the cautious tone.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the quarter ended June 30, 2026 and...

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that an independent Data and Safety Monitoring Board (DSMB...

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that data from its PGN-EDODM1 program will be presented in a...

PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PepGen (PEPG) Upgraded to Buy: Here's What You Should Know

PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

Pictet Asset Management Holding SA Purchases 871,059 Shares of PepGen, Inc. $PEPG

Pictet Asset Management Holding SA lifted its position in shares of PepGen, Inc. (NASDAQ:PEPG - Free Report) by 181.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,352,424 shares of the company's stock...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG...

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of PepGen, Inc. (NASDAQ:PEPG - Get Free Report) have received an average recommendation of "Moderate Buy" from the six analysts that are currently covering the stock, MarketBeat Ratings...

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded on November 9, 2020 and is headquartered in Boston, MA.

PepGen Inc

Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.60
Prev Close	$2.53
Open	$2.56
Dividend Yield	0.00%
50-Day Moving Average	$2.83
Beta	0.72
Avg. Volume	833,984.47
PE Ratio	-1.99

52-Week High	$7.80
52-Week Low	$1.31
Market Capitalization	$180.07M
EPS (Annual)	-$2.12
Price to Book	1.51
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

PEPG Fundamentals